Under way, not recruiting
Comprehensive Prospective Comparison Of Two Robotic Platforms In Anatomical Lung Resections: Clinical Outcomes And Cost-utility Analysis
NCT07537556 · Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal · Updated 17 April 2026
- What is being tested
- da Vinci Xi Surgical System; Versius Surgical System
- For
- Pulmonary Nodule, Solitary; Lung Cancer (NSCLC); Pulmonary Metastases
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 150 people. The full rules are on the registry page.
- Where
- Spain
- When
- Starts or started 1 April 2023, ends 31 July 2026. Registered 17 April 2026.
- Results
- None posted yet.
In the researchers' words
The goal is to compare clinical outcomes, hospital costs, and cost-utility in patients undergoing anatomical lung resections with DaVinci Xi vs Versius platforms The main questions it aims to answer are: * Do patients that undergo an anatomical lung resection with DaVinci Xi have the same clinical outcomes (complications, stay...) than those who were operated with Versius? * Are anatomical lung resections performed with DaVinci Xi more expensive than those performed with Versius? * Are anatomical lung resection performed with DaVinci Xi more cost-effective than those performed with Versius? Participants already undergoing robotic anatomical lung resection as part of their regular medical care will answer quality of life questionnaires preoperatively, at 1, 3, 6, and 12 months after surgery.
Sites
- Hospital Universitario Ramón y CajalMadrid, Madrid, Spain